BACKGROUND: p53 plays an important role in many areas of cellular physiology and biology, ranging from cellular development and differentiation to cell cycle arrest and apoptosis. Many of its functions are attributed to its role in assuring proper cellular division. However, since the establishment of its role in cell cycle arrest, damage repair, and apoptosis (thus also establishing its importance in cancer development), numerous reports have demonstrated additional functions of p53 in various cells. In particular, p53 appears to have important functions as it relates to neurodegeneration and synaptic plasticity. OBJECTIVE: In this review, we will address p53 functions as it relates to various neurodegenerative diseases, mainly its implications in the development of HIV-associated neurocognitive disorders. CONCLUSION: p53 plays a pivotal role in the development of neurodegenerative diseases through its interaction with cellular factors, viral factors, and/or small RNAs that have the ability to promote the development of these diseases. Hence, inhibition of p53 may present an ideal target to restore neuronal functions.
BACKGROUND:p53 plays an important role in many areas of cellular physiology and biology, ranging from cellular development and differentiation to cell cycle arrest and apoptosis. Many of its functions are attributed to its role in assuring proper cellular division. However, since the establishment of its role in cell cycle arrest, damage repair, and apoptosis (thus also establishing its importance in cancer development), numerous reports have demonstrated additional functions of p53 in various cells. In particular, p53 appears to have important functions as it relates to neurodegeneration and synaptic plasticity. OBJECTIVE: In this review, we will address p53 functions as it relates to various neurodegenerative diseases, mainly its implications in the development of HIV-associated neurocognitive disorders. CONCLUSION:p53 plays a pivotal role in the development of neurodegenerative diseases through its interaction with cellular factors, viral factors, and/or small RNAs that have the ability to promote the development of these diseases. Hence, inhibition of p53 may present an ideal target to restore neuronal functions.
Authors: Carlo Bertoni-Freddari; Patrizia Fattoretti; Tiziana Casoli; Giuseppina Di Stefano; Marta Balietti; Belinda Giorgetti; Gemma Perretta Journal: Ann N Y Acad Sci Date: 2009-08 Impact factor: 5.691
Authors: Gareth J Jones; Nicola L Barsby; Eric A Cohen; Janet Holden; Kim Harris; Peter Dickie; Jack Jhamandas; Christopher Power Journal: J Neurosci Date: 2007-04-04 Impact factor: 6.167
Authors: Alexander V Panov; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden; James R Burke; Warren J Strittmatter; J Timothy Greenamyre Journal: Nat Neurosci Date: 2002-08 Impact factor: 24.884
Authors: Charles P Gilman; Sic L Chan; Zhihong Guo; Xiaoxiang Zhu; Nigel Greig; Mark P Mattson Journal: Neuromolecular Med Date: 2003 Impact factor: 4.103
Authors: Ana Cuadrado; Vanesa Lafarga; Peter C F Cheung; Ignacio Dolado; Susana Llanos; Philip Cohen; Angel R Nebreda Journal: EMBO J Date: 2007-03-22 Impact factor: 11.598
Authors: Casmir Turnquist; Yihua Wang; David T Severson; Shan Zhong; Bin Sun; Jingyi Ma; Stefan N Constaninescu; Olaf Ansorge; Helen B Stolp; Zoltán Molnár; Francis G Szele; Xin Lu Journal: Proc Natl Acad Sci U S A Date: 2014-06-23 Impact factor: 11.205